DC DiagnostiCare buys more clinics
Although consolidation of the fixed-site imaging center industry has stalled in the U.S., it continues to thrive north of the border. Fast-growing imaging center firm DC DiagnostiCare of Edmonton, Alberta, announced this month that it has acquired 37
Although consolidation of the fixed-site imaging center industry has stalled in the U.S., it continues to thrive north of the border. Fast-growing imaging center firm DC DiagnostiCare of Edmonton, Alberta, announced this month that it has acquired 37 medical imaging clinics, expanding the company's network by 65%.
The clinics offer services such as x-ray, ultrasound, mammography, fluoroscopy, and bone densitometry and bring in annual revenue of $12.5 million (Canadian). With the acquisition, DC DiagnostiCare now operates 94 clinics in Alberta, Manitoba, Ontario, and British Columbia.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
